OncoSec Medical Inc (ONCSQ)

[hschlauch]

This looks interesting to say the least (in case you missed it).

https://wc2017.electroporation.net/event/program#track-36

In situ priming with concurrent immune checkpoint inhibition: A phase 2 clinical trial of intratumoral plasmid IL-12 with electroporation in combination with pembrolizumab [PL-06]
Alain Algazi Wednesday, 8:30 am — 9:00 am

Local and Systemic Immunotherapy by Electroporation [OR-016]
Adil Daud Monday, 11:10 am — 11:30 am

Intratumoral electroporation of plasmid IL-12 using modified parameters and an optimized DNA plasmid increases immunogenicity in untreated lesions in mice [OR-032]
Shawna Shirley Monday, 2:00 pm — 2:20 pm

DNA-based Antibody Therapy via In Vivo Electrotransfer [OR-124]
Kevin Hollevoet Wednesday, 10:30 am — 10:50 am

These are being presented this week, folks!